|
rs4778137
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The association between rs4778137 genotypes and pathological complete response (pCR, defined that the postoperative pathology indicating no residual invasive breast cancer in the breast or the axillary lymph node) were analyzed.
|
29409738 |
2018 |
|
rs74315364
|
|
|
0.010 |
GeneticVariation |
BEFREE |
RNASEL:p.Glu265* was identified in one of the PALB2 carriers who had two primary invasive breast cancer diagnoses before 50 years.
|
29422015 |
2018 |
|
rs786202998
|
|
|
0.010 |
GeneticVariation |
BEFREE |
RNASEL:p.Glu265* was identified in one of the PALB2 carriers who had two primary invasive breast cancer diagnoses before 50 years.
|
29422015 |
2018 |
|
rs2016347
|
|
|
0.010 |
GeneticVariation |
BEFREE |
In multivariable analysis, patients with primary invasive breast cancer carrying IGF1R_rs2016347 G allele had a significantly increased risk of early tumor progression (hazard ratio (HR) 2.01; adjusted P=0.004) and death (HR 1.84; adjusted P=0.023) compared with patients carrying G/T or T/T, independent of established clinicopathological determinants.
|
23459444 |
2014 |
|
rs505922
|
|
|
0.010 |
GeneticVariation |
BEFREE |
To evaluate the association between genetic variation in the ABO blood group and risk of breast cancer, rs505922 was genotyped in 629 Caucasian women with invasive breast cancer, representing a variety of clinical and pathological tumor types.
|
22642827 |
2012 |
|
rs1131532
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The TNFSF10 (rs1131532) polymorphism was identified as a possible prognostic factor of survival in patients with operated invasive breast cancer.
|
19890662 |
2010 |
|
rs17822931
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Using blood samples from patients with invasive breast cancer (n = 270) and control volunteers (n = 273), the 538G>A SNP in ABCC11 was genotyped using the SmartAmp method.
|
21187511 |
2010 |
|
rs13387042
|
|
|
0.010 |
GeneticVariation |
BEFREE |
2q35-rs13387042 SNP was genotyped for 31 510 women with invasive breast cancer, 1101 women with ductal carcinoma in situ, and 35 969 female control subjects from 25 studies.
|
19567422 |
2009 |
|
rs744154
|
|
|
0.010 |
GeneticVariation |
BEFREE |
In conclusion, our data provide persuasive evidence against an overall association between invasive breast cancer risk and ERCC4 rs744154, TNF rs361525, CASP10 rs13010627, PGR rs1042838, and BID rs8190315 genotypes among women of European descent.
|
19423537 |
2009 |
|
rs12947788
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Among all women, two linked SNPs (D' = 0.99, r(2) = 0.95) on intron 7 (rs12,951,053, rs12,947,788) were associated with modest increases in invasive breast cancer risk; however, associations were only significant for heterozygous carriers.
|
17449902 |
2007 |
|
rs12951053
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Among all women, two linked SNPs (D' = 0.99, r(2) = 0.95) on intron 7 (rs12,951,053, rs12,947,788) were associated with modest increases in invasive breast cancer risk; however, associations were only significant for heterozygous carriers.
|
17449902 |
2007 |
|
rs1462893414
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Association between the estrogen receptor alpha A908G mutation and outcomes in invasive breast cancer.
|
17545528 |
2007 |
|
rs1625895
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The data suggested that additional variants in the 3' UTR (rs9,894,946), and in two correlated SNPs (D' = 0.94, r(2) = 0.81) in introns 6 (rs1,625,895) and 4 (rs2,909,430), were associated with reduced invasive breast cancer risk among women aged 50 and younger only (P(interaction) < 0.03).
|
17449902 |
2007 |
|
rs2909430
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The data suggested that additional variants in the 3' UTR (rs9,894,946), and in two correlated SNPs (D' = 0.94, r(2) = 0.81) in introns 6 (rs1,625,895) and 4 (rs2,909,430), were associated with reduced invasive breast cancer risk among women aged 50 and younger only (P(interaction) < 0.03).
|
17449902 |
2007 |
|
rs662
|
|
|
0.010 |
GeneticVariation |
BEFREE |
In contrast, polymorphisms in PON1 (Gln192Arg) and LEPR (IVS2+6920) were associated with a decreased risk of developing invasive breast cancer.
|
17428620 |
2007 |
|
rs758272654
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Our results suggest that the GNAS1 T393C SNP is a novel genetic host factor for disease progression in patients with invasive breast carcinoma.
|
17186357 |
2007 |
|
rs796065354
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Association between the estrogen receptor alpha A908G mutation and outcomes in invasive breast cancer.
|
17545528 |
2007 |
|
rs965384857
|
|
|
0.010 |
GeneticVariation |
BEFREE |
In contrast, polymorphisms in PON1 (Gln192Arg) and LEPR (IVS2+6920) were associated with a decreased risk of developing invasive breast cancer.
|
17428620 |
2007 |
|
rs9894946
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The data suggested that additional variants in the 3' UTR (rs9,894,946), and in two correlated SNPs (D' = 0.94, r(2) = 0.81) in introns 6 (rs1,625,895) and 4 (rs2,909,430), were associated with reduced invasive breast cancer risk among women aged 50 and younger only (P(interaction) < 0.03).
|
17449902 |
2007 |
|
rs28997576
|
|
|
0.010 |
GeneticVariation |
BEFREE |
The Cys557Ser allele was present at a frequency of 0.028 in patients with invasive breast cancer and 0.016 in controls (odds ratio [OR] = 1.82, 95% confidence interval [CI] 1.11-3.01, p = 0.014).
|
16768547 |
2006 |
|
rs1136201
|
|
|
0.010 |
GeneticVariation |
BEFREE |
Although results from our population-based case-control study show an inverse association between the HER2 Ile655Val polymorphism and risk of invasive breast cancer, most other studies of this single-nucleotide polymorphism suggest an overall null association.
|
15987431 |
2005 |